CN103601666B - The preparation method of octahydro pentamethylene [C] pyrroles - Google Patents

The preparation method of octahydro pentamethylene [C] pyrroles Download PDF

Info

Publication number
CN103601666B
CN103601666B CN201310627653.8A CN201310627653A CN103601666B CN 103601666 B CN103601666 B CN 103601666B CN 201310627653 A CN201310627653 A CN 201310627653A CN 103601666 B CN103601666 B CN 103601666B
Authority
CN
China
Prior art keywords
pyrroles
preparation technology
octahydro pentamethylene
reductive agent
thf
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201310627653.8A
Other languages
Chinese (zh)
Other versions
CN103601666A (en
Inventor
赵长阔
李晓飞
王先恒
王兴华
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zunyi Medical University
Original Assignee
Zunyi Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zunyi Medical University filed Critical Zunyi Medical University
Priority to CN201310627653.8A priority Critical patent/CN103601666B/en
Publication of CN103601666A publication Critical patent/CN103601666A/en
Application granted granted Critical
Publication of CN103601666B publication Critical patent/CN103601666B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/52Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

The invention provides a kind of preparation method of octahydro pentamethylene [C] pyrroles (I); The method, by under Lewis acid promotion, obtains octahydro pentamethylene [C] pyrroles (I) by boron reductive agent reduction ring valeryl group with imine moiety (II) single stage method.

Description

The preparation method of octahydro pentamethylene [C] pyrroles
Technical field
The invention belongs to chemical pharmacy field, relate to the preparation method of crucial synthetic intermediate octahydro pentamethylene [C] pyrroles (octahydrocyclopenta [c] pyrrole, CAS No. is 5661-03-0) of medicine particularly.
Background technology
Hepatitis C virus is the linear positive chain RNA virus of a kind of sub-thread, and due to various chronic hepatopathy can be caused to occur, hepatitis C virus is one of primary killers of mankind's death because of disease up to now.2011 FDA (Food and Drug Adminstration) (FDA) have approved VX-960 (Telaprevir) and uncle match a Wei (Boceprevir) two small-molecule drugs go on the market in the U.S..The listing of these two proteinase inhibitor, changes the result for the treatment of of the third liver during the last ten years in the past; This is larger breakthrough in the third liver treatment field.
Octahydro pentamethylene [C] pyrroles (or its salt) is a kind of medicine intermediate very useful in pharmaceutical synthesis.It is not only the key intermediate of synthesis VX-960 (Telaprevir), but also is the synthetic intermediate of diabetes medicament gliclazide (gliclazide).Therefore, for its large-scale industrial production, there is very important marketable value.Octahydro pentamethylene [C] pyrroles is following structural formula (I):
The preparation method of octahydro pentamethylene [C] pyrroles has bibliographical information very early: R.Griot at Helv.Chim.Acta., 1959,67-72 magazine proposes first a direct synthetic method in nineteen fifty-nine; Griot adopts LiAlH 4in tetrahydrofuran solution, reduce ring valeryl imines (II), obtain target compound octahydro pentamethylene [C] pyrroles (I) with 51% yield.
WO2009/55467 reports another synthetic method: N-benzyl rings valeryl imines is first through LiAlH 4after reduction, re-use 10% palladium carbon (Pd/C) hydrogenating reduction with 55% total recovery two step obtain target compound octahydro pentamethylene [C] pyrroles (I).The method flow process is as follows:
In the industrialization research and development of the pharmaceutical intermediate to octahydro pentamethylene [C] pyrroles, contriver finds that the yield that above two kinds of methods one side obtains the finished product is not high, lower than 55%; All need in addition to use a large amount of lithium aluminum hydride (LiAlH 4), and LiAlH 4be the highstrung chemical reagent of a kind of chance water, laboratory is when applying, because usage quantity is little, risk level can also be tolerated; But in suitability for industrialized production, because usage quantity is large, its danger is very large, in reduction reaction process and the excessive reductive agent LiAlH of aftertreatment 4time can very exothermic, when localized heat is uneven, be very easy to security incidents such as blasting.Generally speaking, during chemical industryization is produced, should avoid using as LiAlH 4so highstrung chemical reagent of chance water.
Up to now, also not reporting the industrialized preparing process of octahydro pentamethylene [C] pyrroles, quantizing production method in the urgent need to finding a kind of effective industry of safe and high yield.
Summary of the invention
The object of this invention is to provide a kind of preparation method meeting octahydro pentamethylene [C] pyrroles (I) of suitability for industrialized production.
For achieving the above object, the present invention after extensive studies it, devise and prepare the new method being different from prior art of octahydro pentamethylene [C] pyrroles, namely under suitable reductive agent and suitable promotor act on, obtain target compound octahydro pentamethylene [C] pyrroles (I) by " single stage method " direct-reduction by ring valeryl imines (II).
Specifically, the preparation method of octahydro pentamethylene [C] pyrroles (I) provided by the invention, comprise reaction substrate ring valeryl imines (II) under boron reductive agent and lewis promoters effect, in appropriate solvent, react at moderate temperatures, obtain target compound octahydro pentamethylene [C] pyrroles (I).
In a kind of embodiment, described suitable reductive agent is selected from sodium borohydride or POTASSIUM BOROHYDRIDE; Preferred sodium borohydride.
In a kind of embodiment, described lewis promoters is selected from zinc chloride, calcium chloride, iron(ic) chloride, iron protochloride, magnesium chloride etc.; More preferably, described lewis promoters is zinc chloride.
In a kind of embodiment, described appropriate solvent is inert solvent; Described inert solvent is selected from tetrahydrofuran (THF), acetonitrile, 1,4-dioxane, toluene, dimethylbenzene, benzene, glycol dimethyl ether, ethylene glycol monomethyl ether, DMF, methyl-sulphoxide, chloroform single solvent or wherein two or more mixed solvent.Preferably, solvent is tetrahydrofuran (THF) or toluene, or both mixed solvents.
In a kind of embodiment, reaction uses single solvent, and temperature of reaction is the reflux temperature of solvent for use.
In a kind of embodiment, reaction uses mixed solvent, and temperature of reaction is arbitrary temp between the boiling point of each solvent used or the azeotropic temperature of this mixed solvent.
In a kind of embodiment, the mol ratio of described reductive agent and reaction substrate (II) is 1:1 to 10:1; Preferred 1.1:1 to 5:1.
In a kind of embodiment, the mol ratio of described promotor and reaction substrate (II) is 0.5:1 to 10:1; Preferred 1.1:1 to 5:1.
Compared with current published technology, novel preparation method of the present invention is by reduction ring valeryl group with imine moiety (II), single stage method prepares octahydro pentamethylene [C] pyrroles (I), advantage is, have employed low price on the one hand, and reaction temperature and, operational safety go back original reagent, on the other hand improve the reactive behavior of going back original reagent by suitable Lewis acid, the higher and purity of product yield is also high (>97%).Therefore this novel method adopt reagent safety, reaction conditions is gentle, product yield is high; Suitability for industrialized production can be met well.
Following examples are only illustrate the present invention further, there is no the intention limiting the invention to this specific embodiment.One skilled in the art would recognize that and present invention encompasses all possible alternatives, improvement project and equivalents in Claims scope.
Embodiment
Raw material and reagent:
Ring valeryl imines (II) (self-control is formed by 1,2-ring penta dioctyl phthalate and urine dehydrating condensation according to existing document);
Sodium borohydride, POTASSIUM BOROHYDRIDE, zinc chloride, iron(ic) chloride and other solvent used and reagent are Chemical Reagent Co., Ltd., Sinopharm Group to be provided.
Embodiment 1
Under nitrogen atmosphere, be equipped with in the there-necked flask of the 5L of mechanical stirrer toward one and add tetrahydrofuran (THF) (500mL), toluene (1.5L), sodium borohydride (68.40g successively, 2.5eq.) with zinc chloride (125.0g, 1.3eq.).Gained suspended substance is heated to backflow.Slowly steam tetrahydrofuran (THF), temperature is controlled at 90 ± 5 DEG C, until there is black solid to generate.Drip tetrahydrofuran (THF) (500mL) solution of ring valeryl imines (100g, 0.72mol), and backflow is spent the night at this temperature.Cooling, is neutralized to pH=2-3 with dilute hydrochloric acid, and divide and go organic phase, aqueous phase ethyl acetate (1L x3) extracts three times, divides and goes organic phase.After being with acid water layer saturated solution of sodium carbonate to be neutralized to pH=8-9, extract by ethyl acetate (1L x3).The organic phase dried over mgso merged.After filtration, filtrate reduced in volume.Obtain white solid octahydro pentamethylene [C] pyrroles (72.8g, 90.9%), HPLC purity is 97%.
Embodiment 2
Under nitrogen atmosphere, be equipped with in the there-necked flask of the 500mL of mechanical stirrer toward one and add tetrahydrofuran (THF) (50mL), toluene (150mL), sodium borohydride (6.84g successively, 2.5eq.) with zinc chloride (12.5g, 1.3eq.).Gained suspended substance is heated to backflow.Slowly steam tetrahydrofuran (THF), temperature is controlled at 90 ± 5 DEG C, until there is black solid to generate.Drip tetrahydrofuran (THF) (50mL) solution of ring valeryl imines (10g, 72mmol), and backflow is spent the night at this temperature.Cooling, is neutralized to pH=2-3 with dilute hydrochloric acid, and divide and go organic phase, aqueous phase ethyl acetate (100mL x3) extracts three times, divides and goes organic phase.After being with acid water layer saturated solution of sodium carbonate to be neutralized to pH=8-9, extract by ethyl acetate (100mL x3).The organic phase dried over mgso merged.After filtration, filtrate reduced in volume.Obtain white solid octahydro pentamethylene [C] pyrroles (7.35g, 91.8%), HPLC purity is 97%.
Embodiment 3
Under nitrogen atmosphere, be equipped with in the there-necked flask of the 500mL of mechanical stirrer toward one and add tetrahydrofuran (THF) (50mL), toluene (150mL), POTASSIUM BOROHYDRIDE (9.76g successively, 2.5eq.) with zinc chloride (14.4g, 1.5eq.).Gained suspended substance is heated to backflow.Slowly steam tetrahydrofuran (THF), temperature is controlled at 90 ± 5 DEG C, until there is black solid to generate.Drip tetrahydrofuran (THF) (50mL) solution of ring valeryl imines (10g, 72mmol), and backflow is spent the night at this temperature.Cooling, is neutralized to pH=2-3 with dilute hydrochloric acid, and divide and go organic phase, aqueous phase ethyl acetate (100mL x3) extracts three times, divides and goes organic phase.After being with acid water layer saturated solution of sodium carbonate to be neutralized to pH=8-9, extract by ethyl acetate (100mL x3).The organic phase dried over mgso merged.After filtration, filtrate reduced in volume.Obtain white solid octahydro pentamethylene [C] pyrroles (7.33g, 91.6%), HPLC purity is 97%.
Embodiment 4
Under nitrogen atmosphere, be equipped with in the there-necked flask of the 250mL of mechanical stirrer toward one and add acetonitrile (25mL), dimethylbenzene (75mL), sodium borohydride (4.93g successively, 3.0eq.) with iron(ic) chloride (11.5g, 2.0eq.).Gained suspended substance is heated to 90 ± 5.Slowly steam tetrahydrofuran (THF), temperature is controlled at 90 ± 5 DEG C, until there is black solid to generate.Drip tetrahydrofuran (THF) (50mL) solution of ring valeryl imines (5g, 36mmol), and spend the night at this temperature.Cooling, is neutralized to pH=2-3 with dilute hydrochloric acid, and divide and go organic phase, aqueous phase ethyl acetate (100mL x3) extracts three times, divides and goes organic phase.After being with acid water layer saturated solution of sodium carbonate to be neutralized to pH=8-9, extract by ethyl acetate (100mL x3).The organic phase dried over mgso merged.After filtration, filtrate reduced in volume.Obtain white solid octahydro pentamethylene [C] pyrroles (3.26g, 81.4%), HPLC purity is 95%.
Embodiment 5
Under nitrogen atmosphere, be equipped with in the there-necked flask of the 250mL of mechanical stirrer toward one and add tetrahydrofuran (THF) (25mL), dimethylbenzene (75mL), POTASSIUM BOROHYDRIDE (11.22g successively, 5.0eq.) with zinc chloride (19.32g, 4.0eq.).Gained suspended substance is heated to 90 ± 5 DEG C.Slowly steam tetrahydrofuran (THF), temperature is controlled at 90 ± 5 DEG C, until there is black solid to generate.Drip tetrahydrofuran (THF) (50mL) solution of ring valeryl imines (5g, 36mmol), and spend the night at this temperature.Cooling, is neutralized to pH=2-3 with dilute hydrochloric acid, and divide and go organic phase, aqueous phase ethyl acetate (50mL x3) extracts three times, divides and goes organic phase.After being with acid water layer saturated solution of sodium carbonate to be neutralized to pH=8-9, extract by ethyl acetate (50mL x3).The organic phase dried over mgso merged.After filtration, filtrate reduced in volume.Obtain white solid octahydro pentamethylene [C] pyrroles (3.65g, 91.2%), HPLC purity is 96%.

Claims (6)

1. the preparation technology of octahydro pentamethylene [C] pyrroles I, it is characterized in that, by reaction substrate ring valeryl imines II under boron reductive agent, lewis promoters effect, react in appropriate solvent, under proper temperature, obtain target compound octahydro pentamethylene [C] pyrroles I; Chemical reaction is shown in following formula:
Described boron reductive agent is sodium borohydride or POTASSIUM BOROHYDRIDE, and described lewis promoters is zinc chloride,
Described appropriate solvent is selected from two or more the mixed solvent in tetrahydrofuran (THF), toluene, dimethylbenzene,
Described proper temperature is arbitrary temp between the boiling point of each solvent used or the azeotropic temperature of this mixed solvent.
2. preparation technology as claimed in claim 1, it is characterized in that, described appropriate solvent is selected from the mixed solvent of tetrahydrofuran (THF) and toluene.
3. preparation technology as claimed in claim 1, it is characterized in that, the mol ratio of described reductive agent and reaction substrate ring valeryl imines II is 1:1 to 10:1.
4. preparation technology as claimed in claim 3, it is characterized in that, the mol ratio of described reductive agent and reaction substrate ring valeryl imines II is 1.1:1 to 5:1.
5. preparation technology as claimed in claim 1, it is characterized in that, the mol ratio of described promotor and reaction substrate ring valeryl imines II is 0.5:1 to 10:1.
6. preparation technology as claimed in claim 5, it is characterized in that, the mol ratio of described promotor and reaction substrate ring valeryl imines II is 1:1 to 5:1.
CN201310627653.8A 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles Expired - Fee Related CN103601666B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310627653.8A CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310627653.8A CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Publications (2)

Publication Number Publication Date
CN103601666A CN103601666A (en) 2014-02-26
CN103601666B true CN103601666B (en) 2015-09-02

Family

ID=50119950

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310627653.8A Expired - Fee Related CN103601666B (en) 2013-11-28 2013-11-28 The preparation method of octahydro pentamethylene [C] pyrroles

Country Status (1)

Country Link
CN (1) CN103601666B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109206357A (en) * 2017-07-04 2019-01-15 浙江九洲药业股份有限公司 A kind of general formula compound and its preparation method and application of gliclazide intermediate
CN109438325A (en) * 2018-12-05 2019-03-08 兰州大学 A kind of method of ring valeryl imines catalytic hydrogenation synthesis octahydro pentamethylene [C] pyrroles
CN116283719B (en) * 2023-03-28 2023-09-08 安徽金鼎医药股份有限公司 Preparation process and preparation system of gliclazide intermediate amino heterocyclic hydrochloride
CN117510394A (en) * 2023-11-08 2024-02-06 内蒙古源宏精细化工有限公司 Preparation method of N-amino-3-azabicyclo [3, 0] octane hydrochloride

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101235011A (en) * 2008-03-11 2008-08-06 浙江大学 N-amino-1,2-cyclopentanediformylimine and preparation method thereof
CN101381338A (en) * 2007-09-03 2009-03-11 上海医药工业研究院 Method for preparing cis-hexahydroisoindoline
WO2009140279A2 (en) * 2008-05-12 2009-11-19 Concert Pharmaceuticals, Inc. Sulfonyl urea compounds
CN102816102A (en) * 2011-06-08 2012-12-12 瑟维尔实验室 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
CN102924362A (en) * 2012-10-26 2013-02-13 浙江工业大学 Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride
WO2013050301A1 (en) * 2011-10-03 2013-04-11 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
TW201341358A (en) * 2012-01-06 2013-10-16 Lonza Ag Method for preparation of octahydrocyclopenta[c] pyrrole

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004131399A (en) * 2002-10-08 2004-04-30 Ihara Chem Ind Co Ltd Method for producing cis-hexahydroisoindoline

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101381338A (en) * 2007-09-03 2009-03-11 上海医药工业研究院 Method for preparing cis-hexahydroisoindoline
CN101235011A (en) * 2008-03-11 2008-08-06 浙江大学 N-amino-1,2-cyclopentanediformylimine and preparation method thereof
WO2009140279A2 (en) * 2008-05-12 2009-11-19 Concert Pharmaceuticals, Inc. Sulfonyl urea compounds
CN102816102A (en) * 2011-06-08 2012-12-12 瑟维尔实验室 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
WO2013050301A1 (en) * 2011-10-03 2013-04-11 Syngenta Participations Ag Enantionselective processes to insecticidal 3-aryl-3-trifluoromethyl-substituted pyrrolidines
TW201341358A (en) * 2012-01-06 2013-10-16 Lonza Ag Method for preparation of octahydrocyclopenta[c] pyrrole
CN102924362A (en) * 2012-10-26 2013-02-13 浙江工业大学 Preparation method of hexahydro-2-cyclopentyl-pyrryl amine hydrochloride

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
A practical and efficient procedure for reduction of carboxylic acids and their derivatives: use of KBH4–MgCl2;You-Chun Qiu,等;《Tetrahedron Letters》;20070904;第48卷(第43期);第7595-7598页 *
硼氢化钠在有机合成中的新应用;车荣睿;《化学试剂》;19861231;第8卷(第02期);第94-98页 *

Also Published As

Publication number Publication date
CN103601666A (en) 2014-02-26

Similar Documents

Publication Publication Date Title
CN103601666B (en) The preparation method of octahydro pentamethylene [C] pyrroles
Huang et al. Construction of optically active quaternary propargyl amines by highly enantioselective zinc/BINOL‐catalyzed alkynylation of ketoimines
An et al. N-Phosphonyl/phosphinyl imines and group-assisted purification (GAP) chemistry/technology
Luo et al. Asymmetric ring-opening of oxabenzonorbornadiene with amines promoted by a chiral iridium-monophosphine catalyst
CN103864885B (en) The application of 1-hydroxyl-1,2,3-phentriazine-4 (3H)-one in Peptide systhesis
CN103553857A (en) Method for preparing o-trifluoromethyl phenylamine and derivatives thereof
CN105541714A (en) Preparation methods of papaverine and papaverine hydrochloride
Jia et al. Visible Light Induced Copper‐Catalyzed Enantioselective Deaminative Arylation of Amino Acid Derivatives Assisted by Phenol
CN103012268B (en) Novel preparation method for ivabradine
CN102731333A (en) Method for preparing tetracaine
CN103588750B (en) Method for preparing ticagrelor intermediate
CN106892826B (en) A kind of preparation method and application of amine and imines N-methyl
CN102010317B (en) Method for synthesizing felbinac and derivatives thereof
CN104478746A (en) Preparation method of DL-lysine
CN106518747A (en) New method for preparing gliclazide intermediate
CN105622583A (en) Novel preparation method for novel anti-hepatitis C drug-daklinza
CN102304102B (en) Preparation method of 1-methyl piperazine
CN107344944A (en) A kind of method for preparing DRV intermediate
Kaldun et al. Enantioselective borane reduction of ketones catalyzed by tricyclic 1, 3, 2-oxazaborolidines
CN102702196B (en) Method for synthesizing 3-methyl-7-diazaindene
CN102766072B (en) Method for preparing atorvastatin calcium chiral side chain
CN104592309A (en) Preparation method of chiral amino acid
CN104356073A (en) Microwave-assisted high-efficiency method for synthesizing 5-cyanouracil
Chen et al. Palladium catalyzed cross-dimerization of terminal acetylenes and acrylates
CN109336832A (en) A kind of polypeptide condensing agent and preparation method thereof for polypeptide drug synthesis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20150902

Termination date: 20201128

CF01 Termination of patent right due to non-payment of annual fee